Yuanyuan Han
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- interferon and immune responses 4
-
- RNA modifications and cancer 5
- Gut microbiota and health 4
-
- Ferroptosis and cancer prognosis 6
- Renal cell carcinoma treatment 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yuanyuan Han
55 papers receiving 663 citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 116
- Complementary and alternative medicine 47
- Cancer Research 85
- Immunology 83
- Molecular Biology 249
Countries citing papers authored by Yuanyuan Han
This map shows the geographic impact of Yuanyuan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Han more than expected).
Fields of papers citing papers by Yuanyuan Han
This network shows the impact of papers produced by Yuanyuan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Han. The network helps show where Yuanyuan Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanyuan Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 30 | |
| 9 | 2022 | 22 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 0 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 30 | |
| 18 | 2019 | 5 | |
| 19 | 2015 | 3 | |
| 20 | A case of pulmonary diffuse alveolar amyloidosis localized in the lung. | 1998 | 2 |
About Yuanyuan Han
Yuanyuan Han is a scholar working on Nephrology, Infectious Diseases and Epidemiology, having authored 60 papers that have together received 671 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers), interferon and immune responses (4 papers), COVID-19 Clinical Research Studies (4 papers), Gut microbiota and health (4 papers), Renal cell carcinoma treatment (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). The work is most often cited by research in Infectious Diseases (116 citations), Complementary and alternative medicine (47 citations) and Cancer Research (85 citations). Yuanyuan Han has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jiejie Dai, Caixia Lü, Xiaomei Sun, Dexuan Kuang, Jie Meng, Xiaohua Liao, Zhangzhe Peng, Mao Jiang, Wenguang Wang and Zhijian Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.